What is the minimum order quantity?

The minimum order quantity is 1000 pieces.

What payment terms are accepted?

Accepted payment terms include T/T, LC, and D/P.

Is customization service available?

Yes, full customization is available from designs and samples.

Premium 5000iu/5ml Sodium Heparin Injection for Medical Use

Name: Premium 5000iu/5ml Sodium Heparin Injection for Medical Use
Brand: Anhui Medipharm Co., Ltd.
SKU: 1947672101

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$2.00-4.00

50,000 boxes

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For oral administration

Model NO.

AMC14085

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Deliver Time

30-40days

Transport Package

24X0.5ml

Specification

5000IU/5ML, 25000IU/5ML, 1000IU/ML

Trademark

Medipharm/Shinepharm/OEM

Origin

China

HS Code

3004909099

Production Capacity

100000 Boxes/Day

Key features

Effective Anticoagulant: Prevents and treats thrombosis, embolism, and DIC with proven clinical efficacy.

Versatile Administration: Available for deep subcutaneous, intravenous injection, and intravenous infusion.

Broad Patient Coverage: Suitable for elderly, children, and adults with specific dosage adjustments.

Low Toxicity Profile: Features low toxicity with manageable adverse reactions under medical supervision.

Customization Available: Offers full customization from designs and samples for specific requirements.

ISO Certified Quality: Manufactured under ISO45001:2018 and ISO14001 certified management systems.

Fast Delivery: Standard delivery time of 30-40 days for international orders.

Experienced Exporter: 14 years of export experience with 80-100% repeat buyer rate.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.68h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.

Product Q&A

Q:What are the main indications for this product?

It is used for the prevention and treatment of thrombosis, embolism, myocardial infarction, pulmonary embolism, and disseminated intravascular coagulation (DIC). It is also used for hemodialysis and anticoagulation during surgery.

Q:How should the dosage be administered?

Dosage varies by method: Deep subcutaneous injection (5,000-10,000 units initially), Intravenous injection (5,000-10,000 units), or Intravenous infusion (20,000-40,000 units daily). Pediatric and elderly dosages require specific weight-based adjustments.

Q:What are the contraindications for using this drug?

It is contraindicated for patients allergic to heparin, those with spontaneous bleeding tendencies, hemophilia, ulcer disease, trauma, postpartum hemorrhage, or severe liver insufficiency.

Q:What are the potential adverse reactions?

Main reactions include spontaneous bleeding from excessive medication, allergic reactions, thrombocopenia (first 5-9 days), hair loss, diarrhea, and potential osteoporosis with long-term use.

Q:Does this product interact with other medications?

Yes. It interacts with coumarin, aspirin, NSAIDs, corticosteroids, and certain antibiotics like kanamycin and gentamicin, potentially increasing bleeding risk or reducing efficacy.